OctariusRx, LLC

Home
United States
Pembroke, MA
OctariusRx, LLC

Providing pharmacy consultation services. Patient safety, regulatory compliance and survey success.

OctariusRx is a pharmacy consulting firm relentlessly focused on providing exceptional care to patients and exceptional services to our organizational partners and clients. Our dedicated and experienced professionals strive to improve quality of care while maintaining the high standards of those we serve. Our Founder, Victor Alves, PharmD, BCGP, FASCP has over twenty years of direct patient care and safe medication management experience in the pharmacy field.

02/16/2026

`🚨 New for 2026: The OctariusRx Controlled Substances Assessment Quiz is live.

This updated annual competency tool reflects current DEA guidance and industry best practices — covering recordkeeping, reconciliations, multi-dose vial management, reporting responsibilities, and more. It’s designed to educate teams, identify gaps, and provide documentation you can show during inspections.

If your ASC or healthcare facility needs a practical way to assess staff competency and strengthen diversion-prevention efforts, we can help.

Contact OctariusRx to schedule your assessment and get the 2026 quiz with a full answer key. `

https://octariusrx.com/the-2026-controlled-substances-assessment-quiz/

Annual 2026 Controlled Substances Assessment Quiz from OctariusRx — updated DEA guidance, answer key, and tools to improve ASC compliance and patient safety.

02/02/2026

🚨 Drug Shortages Continue to Challenge Healthcare

Drug shortages are no longer rare disruptions — they’ve become an ongoing reality across U.S. healthcare. For Ambulatory Surgery Centers (ASCs), the impact can be immediate and significant: delayed procedures, increased costs, and potential patient safety risks.

In our latest article, OctariusRx breaks down what’s driving these shortages — from manufacturing and supply chain issues to economic pressures — and outlines proactive steps ASCs can take to stay ahead.

💡 Learn how your facility can assess risks, strengthen supply resilience, and protect patient care:
👉 https://octariusrx.com/whats-driving-drug-shortages/

Explore the key causes of drug shortages and how ASCs can plan ahead to maintain safe, reliable patient care.

01/27/2026

💊 Preventing Drug Diversion in Ambulatory Surgery Centers

Drug diversion can happen anywhere — even in the most efficient ASCs. At OctariusRx, we help surgery centers stay one step ahead with pharmacist-led audits, staff training, and compliance support designed to protect patients and prevent risk.

Our consultant pharmacists work directly with ASCs to:
✅ Strengthen medication safety and documentation
✅ Support DEA and accreditation compliance
✅ Identify and close diversion vulnerabilities

Because protecting your patients means protecting your practice. 💙

Learn more about how we can help: https://octariusrx.com/how-a-consultant-pharmacist-helps-prevent-drug-diversion-in-ambulatory-surgery-centers/

Consultant pharmacists help ASCs strengthen compliance and prevent drug diversion through audits, training, and oversight.

01/20/2026

The 2025 MHAUS OR Poster is more than a design update — it’s a critical reminder of the importance of malignant hyperthermia preparedness in ASCs.

The revised poster improves clarity, usability, and alignment with current MH response guidance, helping perioperative teams act quickly when seconds matter.

At OctariusRx, our consultant pharmacists help ASCs ensure emergency protocols, dantrolene availability, and OR resources are survey-ready and staff-ready — not just posted on the wall.
Read our latest blog to learn what’s changed and what it means for your ASC.

https://octariusrx.com/whats-new-in-the-2025-mhaus-or-poster-for-ascs-what-ambulatory-surgery-centers-need-to-know/

Learn what’s changed in the 2025 MHAUS OR poster and how ASCs can strengthen malignant hyperthermia preparedness and survey readiness.

01/05/2026

Drug Shortages Update: January 2026

This week we are once again providing an update on the most recent drug shortages.

Drug shortages are just below 80 different medications, with the Food and Drug Administration (FDA) noting 75 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.

As noted above, the current list stands at 75 products, which is down two from our last update in October. In this week’s client newsletter, we have two separate lists of medications in short supply. The first list covers the most commonly used medications in ambulatory surgery centers, while the second addresses medications commonly used long-term care facilities.

In addition to the two lists of unavailable medications, we are also providing a link to Ten Steps to Dealing with Drug Shortages.

If you’re not a client and would like to benefit from all the resources and updates we provide, contact us today.

This week we discuss the most recent drug shortages, currently just under 80 different medications, and how you can minimize impact on patient care.

01/02/2026

Happy New Year 2026!

As we step into 2026, everyone at OctariusRx extends deep gratitude to our clients, partners, vendors, and friends for making 2025 a year of growth and meaningful progress. Our team worked hard to support regulatory compliance, strengthen patient safety, and deliver tailored pharmacy consulting services — and we couldn’t have done it without your trust.

To long-time partners: thank you for your loyalty. To new clients: welcome — we look forward to building a lasting relationship. To organizations considering a partner for 2026: let us help you improve performance, compliance, and patient outcomes.

Wishing you a prosperous, healthy, and successful 2026. From all of us at OctariusRx — Happy New Year!

https://octariusrx.com/happy-new-year-5/

Happy New Year! As we welcome the New Year, we want to express our heartfelt thanks to all the wonderful folks who partnered with us in 2025.

12/23/2025

Merry Christmas!

As we celebrate this wonderful season, we want to extend our heartfelt gratitude to our clients, partners, families, and friends. Your trust and support made 2025 a truly remarkable year.

Whether you joined us recently or have been part of the OctariusRx family for many years, thank you for allowing us the privilege of serving you. The relationships we’ve built and the confidence you place in our team inspire everything we do.

This season also reminds us that success is rooted in teamwork. We are incredibly grateful for our dedicated, compassionate professionals whose commitment to excellence ensures the highest level of care and service every day.

From all of us at OctariusRx, we wish you and your loved ones a Merry Christmas filled with joy, peace, and good health—and a New Year full of hope and success.

https://octariusrx.com/merry-christmas-6/

Merry Christmas from the OctariusRx team. We wish you and your loved ones a Merry Christmas and Happy New Year!

12/17/2025

Navigating the Trypan Blue Shortage: Practical Guidance for Ophthalmology ASCs

Medication shortages continue to challenge ophthalmology ASCs — and the trypan blue shortage is no exception.

Trypan blue plays a critical role in cataract surgery, and limited availability requires thoughtful, pharmacy-led strategies to protect patient safety while maintaining surgical efficiency.

In our latest OctariusRx blog, we share practical guidance for ASCs, including:
• Responsible conservation strategies
• Clinical considerations for alternative approaches
• Multidisciplinary planning to minimize disruption
• Documentation and regulatory best practices
A proactive, structured response can make all the difference during a shortage.

🔗 Read the full post to learn how your ASC can navigate the trypan blue shortage with confidence.

https://octariusrx.com/navigating-the-trypan-blue-shortage-practical-guidance-for-ophthalmology-ascs/

Ophthalmology ASC guidance on navigating the trypan blue shortage with safe alternatives, conservation strategies, and consultant pharmacist insights.

12/08/2025

The Year in Review: 2025

As 2025 comes to a close, we’re reflecting on the key healthcare topics that shaped the year — from medication safety and DEA inspections to opioid updates and compliance best practices.

At OctariusRx, we help facilities navigate these evolving challenges with confidence and expertise.

👉 Read our full year-end review to stay informed and prepare for a safer, smarter 2026.

This week we review the top stories of 2025.

11/26/2025

Happy Thanksgiving from the OctariusRx family!

We’re grateful for our team members, clients, vendors, and their families. This year we were honored to support ambulatory surgery centers, long-term care facilities, and healthcare teams across the country with patient safety, regulatory compliance, and pharmacy best practices. Your dedication motivates our work every day.

Wishing you a peaceful and joyful holiday with loved ones — thank you for your trust and partnership.

Celebrate Thanksgiving with OctariusRx as we share gratitude for our clients, partners, and healthcare teams nationwide.

11/10/2025

🧪 The 2025 USP 800 Assessment Quiz is here!

With the enforcement of USP Chapter 800, facilities are required to assess staff competency in handling hazardous drugs annually. The OctariusRx USP 800 Assessment Quiz provides both an education and compliance tool to help your team stay prepared, protected, and compliant.

✔ Strengthen staff knowledge
✔ Meet CMS, AAAHC, Quad A, and TJC requirements
✔ Promote a culture of safety and excellence

Don’t wait until your next survey — get ahead with our updated 2025 quiz.

https://octariusrx.com/the-2025-usp-800-assessment-quiz-preparing-your-facility-for-compliance-and-safety/

📞 Contact us today to learn more!
📱 (508) 284-9974
✉️ info@octariusrx.com
🌐 www.octariusrx.com

Ensure USP 800 compliance with OctariusRx’s 2025 assessment quiz—educate, assess, and protect your staff and patients.

11/03/2025

🚨 FDA 2025 Update: Tranexamic Acid Safety Alert

The FDA has issued strengthened warnings for tranexamic acid (TXA), emphasizing IV-only administration and new labeling to prevent catastrophic wrong-route errors.

For Ambulatory Surgery Centers (ASCs), these updates mean stronger compliance expectations, workflow redesign, and renewed focus on medication safety.

At OctariusRx, we’re helping ASCs implement the FDA’s new TXA requirements through improved storage, labeling, barcode verification, and staff training — turning compliance into a competitive advantage.

👉 Stay ahead of change and protect your patients.

Learn more: https://octariusrx.com/2025-fda-updates-on-tranexamic-acid-what-ambulatory-surgery-centers-need-to-know/

FDA 2025 tranexamic acid updates: OctariusRx helps ASCs stay compliant, safe, and fully prepared for new TXA requirements.

Address

125 Church Street Suite 90/163
Pembroke, MA
02359

Telephone

+15082849974

Website

http://OctariusRx.com/

Alerts

Be the first to know and let us send you an email when OctariusRx, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to OctariusRx, LLC:

Shortcuts

Want your practice to be the top-listed Clinic in Pembroke?